Literature DB >> 12670422

APP processing and synaptic function.

Flavio Kamenetz1, Taisuke Tomita, Helen Hsieh, Guy Seabrook, David Borchelt, Takeshi Iwatsubo, Sangram Sisodia, Roberto Malinow.   

Abstract

A large body of evidence has implicated Abeta peptides and other derivatives of the amyloid precursor protein (APP) as central to the pathogenesis of Alzheimer's disease (AD). However, the functional relationship of APP and its proteolytic derivatives to neuronal electrophysiology is not known. Here, we show that neuronal activity modulates the formation and secretion of Abeta peptides in hippocampal slice neurons that overexpress APP. In turn, Abeta selectively depresses excitatory synaptic transmission onto neurons that overexpress APP, as well as nearby neurons that do not. This depression depends on NMDA-R activity and can be reversed by blockade of neuronal activity. Synaptic depression from excessive Abeta could contribute to cognitive decline during early AD. In addition, we propose that activity-dependent modulation of endogenous Abeta production may normally participate in a negative feedback that could keep neuronal hyperactivity in check. Disruption of this feedback system could contribute to disease progression in AD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670422     DOI: 10.1016/s0896-6273(03)00124-7

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  653 in total

1.  Calcineurin inhibition with systemic FK506 treatment increases dendritic branching and dendritic spine density in healthy adult mouse brain.

Authors:  Tara L Spires-Jones; Kevin Kay; Roland Matsouka; Anete Rozkalne; Rebecca A Betensky; Bradley T Hyman
Journal:  Neurosci Lett       Date:  2010-10-21       Impact factor: 3.046

Review 2.  Some evolutionary perspectives on Alzheimer's disease pathogenesis and pathology.

Authors:  Daniel J Glass; Steven E Arnold
Journal:  Alzheimers Dement       Date:  2011-12-03       Impact factor: 21.566

3.  Sensory network dysfunction, behavioral impairments, and their reversibility in an Alzheimer's β-amyloidosis mouse model.

Authors:  Daniel W Wesson; Anne H Borkowski; Gary E Landreth; Ralph A Nixon; Efrat Levy; Donald A Wilson
Journal:  J Neurosci       Date:  2011-11-02       Impact factor: 6.167

Review 4.  Role of APP for dendritic spine formation and stability.

Authors:  Christian K E Jung; Jochen Herms
Journal:  Exp Brain Res       Date:  2011-11-18       Impact factor: 1.972

Review 5.  It's complicated: The relationship between sleep and Alzheimer's disease in humans.

Authors:  Brendan P Lucey
Journal:  Neurobiol Dis       Date:  2020-07-29       Impact factor: 5.996

6.  Diagnostic and prognostic biomarkers for HAND.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2019-01-03       Impact factor: 2.643

7.  mGluR5 Contribution to Neuropathology in Alzheimer Mice Is Disease Stage-Dependent.

Authors:  Khaled S Abd-Elrahman; Alison Hamilton; Awatif Albaker; Stephen S G Ferguson
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-12

8.  Interaction of ASK1 and the beta-amyloid precursor protein in a stress-signaling complex.

Authors:  Veronica Galvan; Surita Banwait; Patricia Spilman; Olivia F Gorostiza; Alyson Peel; Marina Ataie; Danielle Crippen; Wei Huang; Gurleen Sidhu; Hidenori Ichijo; Dale E Bredesen
Journal:  Neurobiol Dis       Date:  2007-07-03       Impact factor: 5.996

Review 9.  Role of Glutamate and NMDA Receptors in Alzheimer's Disease.

Authors:  Rui Wang; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

10.  Beta-amyloid prevents excitotoxicity via recruitment of glial glutamate transporters.

Authors:  Atsushi Baba; Kazuhiko Mitsumori; Maki K Yamada; Nobuyoshi Nishiyama; Norio Matsuki; Yuji Ikegaya
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.